Uwe Reuter

Discontinuation and reinitiation of migraine treatment with GCRP mAbs 1:13
Discontinuation and reinitiation of migraine treatment with GCRP mAbs
Uwe Reuter • 25 Jun 2022
REGAIN trial of galcanezumab in chronic migraine 1:18
REGAIN trial of galcanezumab in chronic migraine
Uwe Reuter • 25 Jun 2022
Unmet needs in migraine: addressing inter-ictal burden 1:51
Unmet needs in migraine: addressing inter-ictal burden
Uwe Reuter • 25 Jun 2022
Challenges in migraine management 2:09
Challenges in migraine management
Uwe Reuter • 22 May 2020
The evolving landscape of migraine treatment and prevention 3:42
The evolving landscape of migraine treatment and prevention
Uwe Reuter • 22 May 2020
Fremanezumab in patients with chronic or episodic migraine 2:52
Fremanezumab in patients with chronic or episodic migraine
Uwe Reuter • 22 May 2020
HER-MES study: erenumab versus topiramate in episodic migraine 2:30
HER-MES study: erenumab versus topiramate in episodic migraine
Uwe Reuter • 22 May 2020
LIBERTY trial: erenumab in episodic migraine patients with prior preventive treatment failures 2:33
LIBERTY trial: erenumab in episodic migraine patients with prior preventive treatment failures
Uwe Reuter • 22 May 2020
The content of VJNeurology is intended for healthcare professionals